» Articles » PMID: 35331047

The Development of the ADO-SQ Model to Predict 1-year Mortality in Patients with COPD

Overview
Journal Palliat Med
Publisher Sage Publications
Specialty Critical Care
Date 2022 Mar 25
PMID 35331047
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Goals of end-of-life care must be adapted to the needs of patients with chronic obstructive pulmonary disease (COPD) who are in the last phase of life. However, identification of those patients is limited by moderate performances of existing prognostic models and by limited validation of the often-recommended surprise question.

Aim: To develop a clinical prediction model to predict 1-year mortality in patients with COPD.

Design: Prospective study using logistic regression to develop a model in two steps: (1) external validation of the ADO, BODEX, or CODEX models (A = age; B = body mass index; C = comorbidity; D = dyspnea; EX = exacerbations; O = airflow obstruction); (2) updating of best performing model and extending it with the surprise question. Discriminative performance of the new model was assessed using internal-external validation and measured with area under the curve (AUC). A nomogram and web application were developed.

Settings/participants: Patients with COPD from five hospitals (September-November 2017).

Results: Of the 358 included patients (median age 69.5 years, 50% male), 63 (17%) died within a year. The ADO index (AUC 0.73) had the best discriminative ability compared to the BODEX (AUC 0.71) or CODEX (AUC 0.68), and was extended with the surprise question. The resulting ADO-surprise question (SQ) model had an AUC of 0.79.

Conclusion: The ADO-SQ model offers improved discriminative performance for predicting 1-year mortality compared to the surprise question, ADO, BODEX, or CODEX. A user-friendly nomogram and web application (https://dnieboer.shinyapps.io/copd) were developed. Further external validation of the ADO-SQ in patient groups is needed.

Citing Articles

Contribution of Anemia to Multidimensional Indices for Predicting Mortality in Hospitalized Patients With Chronic Obstructive Pulmonary Disease (COPD).

Garcia-Pachon E, Padilla-Navas I Cureus. 2024; 16(10):e72126.

PMID: 39575004 PMC: 11580708. DOI: 10.7759/cureus.72126.


Prognostic models and factors identifying end-of-life in non-cancer chronic diseases: a systematic review.

Gebresillassie B, Attia J, Mersha A, Harris M BMJ Support Palliat Care. 2024; 14(e3):e2316-e2329.

PMID: 38580395 PMC: 11672066. DOI: 10.1136/spcare-2023-004656.

References
1.
Bestall J, Paul E, Garrod R, Garnham R, Jones P, Wedzicha J . Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999; 54(7):581-6. PMC: 1745516. DOI: 10.1136/thx.54.7.581. View

2.
Hui D, Park M, Liu D, Paiva C, Suh S, Morita T . Clinician prediction of survival versus the Palliative Prognostic Score: Which approach is more accurate?. Eur J Cancer. 2016; 64:89-95. PMC: 4969216. DOI: 10.1016/j.ejca.2016.05.009. View

3.
Rietjens J, Sudore R, Connolly M, van Delden J, Drickamer M, Droger M . Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative Care. Lancet Oncol. 2017; 18(9):e543-e551. DOI: 10.1016/S1470-2045(17)30582-X. View

4.
White N, Kupeli N, Vickerstaff V, Stone P . How accurate is the 'Surprise Question' at identifying patients at the end of life? A systematic review and meta-analysis. BMC Med. 2017; 15(1):139. PMC: 5540432. DOI: 10.1186/s12916-017-0907-4. View

5.
Steyerberg E, Harrell Jr F . Prediction models need appropriate internal, internal-external, and external validation. J Clin Epidemiol. 2015; 69:245-7. PMC: 5578404. DOI: 10.1016/j.jclinepi.2015.04.005. View